6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
6-month buprenorphine maintenance treatment (BMT) retention
6-month BMT retention is defined as missing two consecutive clinic visits after completing the first two weeks of BMT treatment, to allow for BUP dose stabilization.
Ascertainment of retention is simply by tracking clinic visits and electronic record of the health visit.
Change from Screening in Subjective Opiate Withdrawal Scale (SOWS) at week
The SOWS is a self-administered scale for grading opioid withdrawal symptoms. It contains 16 symptoms whose intensity the patient rates on a scale of 0 (not at all) to 4 (extremely), and takes less than 10 minutes to complete.
Change from Screening in Subjective Opiate Withdrawal Scale (SOWS) at Week 24
The SOWS is a self-administered scale for grading opioid withdrawal symptoms. It contains 16 symptoms whose intensity the patient rates on a scale of 0 (not at all) to 4 (extremely), and takes less than 10 minutes to complete.
Change from Screening in Opioid Craving Scale (OCS) at Week 12 severity rating measures over 1 month
he Opioid Craving Scale, a modification of the Cocaine Craving Scale was used to measure opioid craving.
Change from Screening in Opioid Craving Scale (OCS) at Week 24 severity rating measures over 1 month
he Opioid Craving Scale, a modification of the Cocaine Craving Scale was used to measure opioid craving.
Change from Screening in negative affect severity in the PANAS
The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect.
Change from Screening in negative affect severity in the PANAS
The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect.
Opioid Relapse
Relapse is defined as presence of self-reported repeated (i.e. 2 or more) use after the first two weeks for stabilization of buprenorphine dose, and/or presence of positive urine drug test for opiates. Ascertainment of opioid relapse is through: (a) Survey question administered 2-weekly, inquiring how days in the past did the subject use heroin, prescription opiates and/or other drugs; the dates of drug use; and the quantity (or dose) of drugs used; and (b) Biochemical verification of drug use, through urine samples will be collected and tested every two weeks.
Pre-Intervention changes in SOWS from Screening at Week 2
The SOWS is a self-administered scale for grading opioid withdrawal symptoms. It contains 16 symptoms whose intensity the patient rates on a scale of 0 (not at all) to 4 (extremely).
Post-Intervention changes in SOWS from Week 12 at Week 13
The SOWS is a self-administered scale for grading opioid withdrawal symptoms. It contains 16 symptoms whose intensity the patient rates on a scale of 0 (not at all) to 4 (extremely).
Pre-Intervention changes in OCS from Screening to Week 2
a modification of the Cocaine Craving Scale was used to measure opioid craving.
Post-Intervention changes in OCS from Week 12 to Week 13
a modification of the Cocaine Craving Scale was used to measure opioid craving.
Pre-Intervention changes in PANAS negative affect from Screening visit to Week 2
The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect.
Post-Intervention changes in PANAS negative affect from Week 12 at Week 13
The SOWS is a self-administered scale for grading opioid withdrawal symptoms. It contains 16 symptoms whose intensity the patient rates on a scale of 0 (not at all) to 4 (extremely). The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to assess positive and negative affect.